Agree, with the low tumor burden immediately following surgery, it makes sense. I do think I heard somewhere here that the dying cells from the radiation/chemo help DCVAX to find its targets, but maybe that was DIRECT. L already has its targets from the tumor lysate.
News 
Market Data 
Discover 
